Back
  1. Home
  3. Detailled Reference
Request a copy
Paper published in a journal (Scientific congresses and symposiums)
Inhibition of sclerostin with romosozumab in postmenopausal women with low BMD : phase 2 trial results
McClung, M; Grauer, A; Boonen, S et al.
2013 • In Osteoporosis International, 24 (1), p. 38-S39
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/153966
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
Inhibition of sclerostin with romosozumab in postmenopausal women with low BMD phase 2 trial results.pdf
Publisher postprint (286.38 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Disciplines :
General & internal medicine
Author, co-author :
McClung, M
Grauer, A
Boonen, S
Brown, JP
Diez-Perez, A
Langdahl, BL
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Zanchetta, JR
Katz, L
Maddox, J
Yang, YC
Libanati, C
Bone, HG
More authors (3 more) Less
Language :
English
Title :
Inhibition of sclerostin with romosozumab in postmenopausal women with low BMD : phase 2 trial results
Publication date :
2013
Event name :
European Congress on Osteoporosis and Osteoarthritis (ESCEO13-IOF)
Event organizer :
European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) - International Osteoporosis Foundation (IOF)
Event place :
Rome, Italy
Event date :
Du 17 avril 2013 au 20 avril 2013
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
Volume :
24
Issue :
1
Pages :
S38-S39
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 01 August 2013

Statistics

Number of views
175 (3 by ULiège)
Number of downloads
1 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi